Biocon, Mylan launch insulin biosimilar in Australia

The biotechnology major and pharmaceutical company Mylan N V announced the launch of their insulin biosimilar Semglee.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news